Like most websites The Medicine Maker uses cookies. In order to deliver a
personalized, responsive service and to improve the site, we remember and store information about how you use
it.
Learn more.
Congratulations! You now have unlimited access to all articles from The Medicine Maker.
Complete your profile at your earliest convenience to unlock the rest of your benefits:
relevant and personalised updates about your field
access to White Papers/product profiles
digital magazine subscription
Dolores Schendel
The Power List 2016
Dolores Schendel
Chief Executive Officer, Medigene AG
Dolores has been a member of the German Research Foundation, German Cancer Aid and the European Research Council. She joined Medigene in 2014, when the company acquired Trianta Immunotherapy. She claims to be passionate about bringing individualized immunotherapies from bench to bed-side by moving herself and her team from in-depth research to the forefront of the biotech industry.